|
|
Article: CryoCor Confirms FDA Advisory Panel Meeting.
- Article from:
- PR Newswire
- Article date:
- June 19, 2007
CopyrightCOPYRIGHT 2007 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
- AF Pivotal Trial Enrollment On Track -
SAN DIEGO, June 19 /PRNewswire-FirstCall/ -- CryoCor, Inc. , a medical device company focused on the treatment of cardiac arrhythmias, today provided an update on its clinical progress.
The Company reiterated that it is scheduled to present on June 27, 2007 clinical data related to its pre market approval, or PMA, application for the treatment of atrial flutter, or AFL, at an Advisory Panel meeting. The United States Food and Drug Administration, or FDA, will convene the Advisory Panel meeting to advise the FDA on whether or not the chronic effectiveness data in CryoCor's pivotal trial for the treatment of AFL ...